Cingulate
CING • NASDAQ
Cingulate is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Shane J. Schaffer, with a market cap of $69.3M.
Market Cap$69.3M
Employees13.0
CEOShane J. Schaffer
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
CIN
Cingulate FAQ
Common questions about Cingulate
Cingulate is scheduled to report earnings for Q1 2026 on May 7, 2026.
Cingulate has approximately 13 employees.